scPharmaceuticals Inc. (SCPH)

scPharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-57.71	-54.81	-36.84	-28.03	-32.21	-33
Depreciation & Amortization	0.57	0.63	0.47	0.44	0.4	0.36
Share-Based Compensation	5.32	4.86	2.84	2.37	2	1.45
Other Operating Activities	-8.63	-9.92	-1.05	-1.92	2.12	0.74
Operating Cash Flow	-60.45	-59.24	-34.58	-27.15	-27.69	-30.44
Capital Expenditures	-0.04	-0.04	-0.02	-0.01	0	0
Change in Investments	42.32	20.01	-45.84	32.14	-33.46	0
Investing Cash Flow	42.28	19.97	-45.86	32.13	-33.46	0
Share Issuance / Repurchase	1.33	14.85	47.98	0.05	61.31	4.03
Debt Issued / Paid	0	0	29.3	-2.5	-0.8	9.56
Other Financing Activities	-0.17	-	-0.05	-0.08	-0.16	-
Financing Cash Flow	1.16	14.85	77.23	-2.53	60.35	13.59
Net Cash Flow	-17.01	-24.43	-3.21	2.45	-0.81	-16.85
Free Cash Flow	-60.49	-59.28	-34.6	-27.16	-27.69	-30.44
Free Cash Flow Margin	-343.08%	-436.14%	-	-	-	-
Free Cash Flow Per Share	-1.55	-1.54	-1.22	-0.99	-1.13	-1.64

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).